Basic Information
ID: ALA5163582
Type: Functional
Description: Invivo antagonist activity at V2R in Pkd1 knockout mouse model of autosomal dominant polycystic kidney disease assessed as reduction of renal cyst formation 2 mg/kg, sc administered once daily treatment started from postnatal day 6 to 12 days by hematoxylin and eosin staining based assay
Organism: Mus musculus
Activity Charts
Bioactivity
Activity Types for Assay ALA5163582
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 448.95 | 5.68 | 5.68 |
| 575.15 | 6.00 | 6.00 |
| 573.18 | 7.16 | 7.16 |